Emergent BioSolutions Inc. provided revenue guidance for the first quarter and earnings guidance for the full year of 2024. For the quarter, the company expects total revenues to be in the range of $200 million to $250 million.

For the year, the company expects total revenues to be in the range of $900 million to $1,100 million and net loss to be in the range of $183 million to $133 million.